Trial intelligence / Profile preview

Effect of Dihydrotestosterone (DHT) on Prostate Tissue in Normal Men

NCT00490022Phase 2Completed

Sponsor
University of Washington
Start
Jun 2007
Primary completion
Jan 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of dihydrotestosterone in Hypogonadism, benign prostatic hyperplasia (BPH), sponsored by University of Washington. Started Jun 2007; status: completed.

02

Drugs

dihydrotestosterone
03

Conditions

Hypogonadismbenign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT00490022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00490022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call